Should you have any questions,
please contact Peter Mattonet at:
Phone: +33-1 48 88 96 24
or +33-1 .44 40 01 20
on Tuesdays 14.30 - 18.30
or Thusdays 9.30 - 18.30
(Paris time)

Fax: +33-1 47 66 74 70
Email: peter.mattonet@eurogin.com
www.eurogin.com/2010

•The meeting aims at developing a full review of current scientific developments in the field of cervical cancer control, highlighting recent medical advances made and exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination.

The conference takes place at a crucial time where clinicians are called upon to integrate HPV screening and prophylactic vaccines into clinical practice.

The purpose of the conference is not only to highlight new developments, but also to widen the discussion beyond the purely medical aspects and to address public education issues.

• A review of recent developments in HPV infection and cervical cancer prevention and control.
• Integrate the use of HPV prophylactic vaccines into clinical practice.
• Advising patients about the potential and limitations of HPV prophylactic vaccines.
• Understanding the impact of HPV prophylactic vaccines
• Implementation of guidelines for cervical disease; screening and management of cervical abnormalities.
• Apply HPV DNA testing to clinical practice in a rational and cost-effective way.
• Evaluate different tools and techniques available in the field of HPV infection diagnosis and adapt the most appropriate strategies for patients.
• Anticipate trends in biomarkers and genotyping for diagnosis and prevention.
• Compare worldwide experience in the field of screening and prevention of cervical disease, including developed and developing countries.
• Apply skills to enable the improvement, expansion, and use of scientific data for decision making
• Determine the public health role of physicians in cervical cancer control: prevention through training, early detection, treatment and quality of life.
• Identify existing strategies and explore innovative community interventions for cervical cancer screening outreach and public education.

Program Structure

The EUROGIN 2010 meeting will comprise the following types of sessions:  

1. Training Course
   The training course is designed to provide the most updated educational strategies and experience on HPV infection and associated disease. The topics covered range from the fundamentals to emerging issues and the clinical use of prophylactic HPV vaccines.
   
   
2. Plenary Sessions
   These include lectures giving a broad overview of the essential issues of cervical cancer prevention by the most prominent experts in their respective field.
   
   
3. Scientific Sessions
   These concurrent sessions feature presentations of selected abstracts on new data covering a broad range of topics related to genital cancer prevention and management of patients with HPV associated diseases.
   
   
4. Clinical Sessions
   Scientific sessions focusing on clinical aspects of HPV related diseases, decision making and follow-up. These sessions will include the presentation of case studies.
   
   
5. Debate Time
   Based on feedback from previous meetings, the idea consists of including more time for debate on controversial topics. This could be organized either as separate sessions (debate sessions) be included in plenary and scientific sessions.
   
   
6. Free Communications
   The organizing committee welcomes the presentation of proferred papers, with preference being given to original papers on unpublished data. Abstracts presented must comply with the conditions which will be set out in the "Abstract Submission Conditions" which will soon be posted on the EUROGIN website. The abstract submission deadline is September 15, 2009. Submitted papers will be reviewed by the scientific committee.
   
   
7. Poster Presentations
   Selected submitted papers will be on displayed as posters to be viewed by all congress delegates.

Satellite Symposia
Symposia will be organized by partner companies to offer additional information on recent scientific findings and their impact on clinical practice.

Abstract Topics

For review purposes, abstracts are classified according to the following list

1.     Viral and molecular biology
2.     Genetic predisposition to infection
3.     Epidemiology and natural history
4.     Pathogenesis
5.     Immunology
6.     HPV prophylactic vaccines: clinical aspects
7.     HPV prophylactic vaccines: basic science
8.     HPV therapeutic vaccines
9.     HPV testing
10.   Genotyping
11.   Molecular markers
12.   Screening methods
13.   Liquid based cytology
14.   Automation in cytology
15.   New technologies
16.   Diagnostic procedures
17.   Colposcopy
18.   Cervical neoplasia
19.   Vaginal neoplasia
20.   Vulvar diseases
21.   Anal neoplasia
22.   Genital warts
23.   Sexually transmitted diseases and HIV infection
24.   Conventional therapies
25.   New treatments - Immunotherapy
26.   New drugs
27.   Economics and modelling
28.   Advocacy, acceptability and psychology

The EUROGIN 2010 congress will extend over 4 days:

Day 1 (Wednesday, February 17):

• Training Course
• Free Communications
  

Day 2 (Thursday, February 18):

• WACC (Women Against Cervical Cancer) Forum:
  This is a full day conference to promote awareness and education on HPV infection and cervical disease.
• Plenary Sessions
• Scientific Sessions
• Free Communications
  

Day 3 (Friday, February 19):

• Plenary Sessions
• Scientific Sessions
• Clinical Sessions
• Free Communications
  

Day 4 (Saturday, February 20):

• Scientific Sessions
• Clinical Sessions
• Free Communications

Target Audience

The meeting will gather more than 2,000 professionals from all over the world, including clinicians, gynecologists, epidemiologists, virologists, cytophathologists, oncologists, health communication specialists, health care decision makers, govermental and non-governmental institutions.

EUROGIN 2010 is an international conference which offers an excellent opportunity to meet your colleagues and peers to discuss the most important matters facing their practice in cervical cancer control.

Conference Venue

The EUROGIN 2010 congress will be held in Monte-Carlo, Monaco, at the Grimaldi Forum convention center

GRIMALDI FORUM
10 Avenue Princesse Grace
98001 MONACO
 www.grimaldiforum.com

International airport: NICE Côte d'Azur (France) – 30 minutes by taxi or shuttle bus.

The "GRIMALDI FORUM" is a modern convention center located on the Monaco seashore and close to a large number of hotels.

The registration fees are as follows:

The registration fee includes:

• Opening Ceremony and Welcome Cocktail
• Access to the Training Course on Feb. 17, 2010
• Access to all sessions of the meeting
• Coffee breaks
• Program and presentation handouts

Online registration (secured payment, click here)             

Cancellation policy

Cancellation before December 18, 2009: refund 50 %
Cancellation after December 18, 2009: no refund.
Replacement before December 18, 2009: free of charge.
Replacements after December 18, 2009 are considered as a new registration and subject to payment of the full registration fee at the on-site rate.

Accommodation

The conference organizers have blocked a substantial number of rooms at preferential rates for conference participants (3, 4 and 5 star hotels).

Detailed information and online hotel reservation